Home / Solutions / AccelStudy

Leverage our Ready-to-Use Clinical Study Platform with integrated EDC, Medical Coding, CTMS and Drug Safety Applications

‘AccelStudy’ is a full-managed, cloud-based integrated solutions platform designed for  biopharmaceutical and medical device companies to perform clinical data management, trial management, and manage drug safety functions in a single place. Clients can realize significant benefits almost immediately with a ready-to-use, validated and industry recognized application suite. Our flexible pricing model can lower the total cost of ownership.

What is Offered with AccelStudy

The ‘AccelStudy’ platform has a robust EDC, CTMS and a Drug Safety System which allows clients to centrally manage the entire lifecycle of a clinical study. It also includes the study design support services from Techsol for setting up sites, investigators, study visits and the associated case report forms.

Solution Subscription Model

  • Clients can subscribe for one study or for multiple studies in a program by selecting only the required modules for their business need
  • The technical solution is offered with ancillary services such as Study Build, Edit Checks Programming, Setting up Data Extraction schedules, and developing custom reports
  • Additional System integrations with eCOA, IVRS/IWRS, etc. can be optionally selected as part of the subscription
Clinical Cloud

How Do We Deliver

‘AccelStudy’ is delivered on a GxP compliant fully-managed cloud platform hosted on Amazon Web Services (AWS) which has security and quality certifications such as ISO 9001, ISO 27001, ISO 27017 and ISO 27018.

All ongoing systems validation and preventive maintenance of the AccelStudy platform and associated add-on applications will be managed by Techsol throughout the business lifecycle.

Why ‘AccelStudy’ is an ideal choice for Clients?

  • Techsol owns the responsibility for the end-to-end management of all applications
  • Burden of validation & compliance management is significantly reduced
  • Security option with Single sign-on is available
  • Includes all future application version upgrades, dictionary upgrades, and security updates
  • Considerably reduces Total Cost of Ownership (TCO)

New Insights

4 Effective Strategies to Accelerate Site Selection to Activation

Introduction to the site selection process Clinical research organizations (CRO) predominantly rely on the internal networks and investigator database to support a clinical study for a drug. As the clinical sphere continues to expand at a rapid pace, there is an upsurge in demand for clinical trial sites worldwide. CROs are striving for new sites […]

Aggregate Reporting – Significance, Classification and Challenges

Aggregate reports are the cumulative reports in the database that emphasise on evaluation of safety profile and risk-benefit analysis of a drug. Aggregate reporting is the process of compilation and submission of aggregate reports to the regulatory agencies over the period of the product’s life cycle (during pre-marketing and post-marketing phase) to provide a comprehensive [...]

Literature Screening – Process overview, challenges en-route and the scope for automation

Medical and scientific literature is a valuable source of safety information that helps in monitoring benefit-risk profiles and emerging safety issues of medicinal products. Literature screening is conducted to ascertain abstracts and articles that provide crucial information on serious and non-serious Individual Case Safety Reports (ICSR) reports and risk-benefit assessment of a drug. The scientific […]

Get in Touch with Us